Xiaoyong Lu

498 total citations
17 papers, 382 citations indexed

About

Xiaoyong Lu is a scholar working on Molecular Biology, Nephrology and Rheumatology. According to data from OpenAlex, Xiaoyong Lu has authored 17 papers receiving a total of 382 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 7 papers in Nephrology and 4 papers in Rheumatology. Recurrent topics in Xiaoyong Lu's work include Gout, Hyperuricemia, Uric Acid (7 papers), Advanced Chemical Sensor Technologies (2 papers) and Inflammasome and immune disorders (2 papers). Xiaoyong Lu is often cited by papers focused on Gout, Hyperuricemia, Uric Acid (7 papers), Advanced Chemical Sensor Technologies (2 papers) and Inflammasome and immune disorders (2 papers). Xiaoyong Lu collaborates with scholars based in China, United Kingdom and United States. Xiaoyong Lu's co-authors include Huaxiang Wu, Mo Chen, Yujie Jiang, Menglu Chen, Xuyan Yang, Jin Lin, Xiaoying Zhao, Liuyan Nie, David J. Hunter and Masayuki Kimura and has published in prestigious journals such as Annals of the Rheumatic Diseases, Meat Science and Arthritis Research & Therapy.

In The Last Decade

Xiaoyong Lu

17 papers receiving 375 citations

Peers

Xiaoyong Lu
Yoo Jin Shin South Korea
Margaret Salfi United States
Na Song China
Dong Won Lee South Korea
Hui Du China
Xiaoyong Lu
Citations per year, relative to Xiaoyong Lu Xiaoyong Lu (= 1×) peers Denise Clavijo‐Cornejo

Countries citing papers authored by Xiaoyong Lu

Since Specialization
Citations

This map shows the geographic impact of Xiaoyong Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoyong Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoyong Lu more than expected).

Fields of papers citing papers by Xiaoyong Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoyong Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoyong Lu. The network helps show where Xiaoyong Lu may publish in the future.

Co-authorship network of co-authors of Xiaoyong Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoyong Lu. A scholar is included among the top collaborators of Xiaoyong Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoyong Lu. Xiaoyong Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Yang, Hao, et al.. (2024). Dietary anthocyanin is associated with a lower prevalence of hyperuricemia independently of metabolic syndrome among females: Results from NHANES 2007–2010 and 2017–2018. International Journal of Rheumatic Diseases. 27(5). e15193–e15193. 1 indexed citations
2.
Zhang, Peiyu, et al.. (2022). Febuxostat Therapy for Patients with Gout and Stage 2–4 CKD: a Retrospective Study. Rheumatology and Therapy. 9(5). 1421–1434. 3 indexed citations
3.
Zhang, Peiyu, et al.. (2022). The role of gut microbiota in gout: Is gut microbiota a potential target for gout treatment. Frontiers in Cellular and Infection Microbiology. 12. 1051682–1051682. 34 indexed citations
4.
Chen, Mo, Chenyi Ye, Peiyu Zhang, et al.. (2020). Bergenin as a Novel Urate-Lowering Therapeutic Strategy for Hyperuricemia. Frontiers in Cell and Developmental Biology. 8. 703–703. 33 indexed citations
5.
Lu, Xiaoyong, et al.. (2019). IL‐1β functionally attenuates ABCG2 and PDZK1 expression in HK‐2 cells partially through NF‐ĸB activation. Cell Biology International. 43(3). 279–289. 18 indexed citations
6.
Nie, Liuyan, et al.. (2019). Meta-analysis: compared with anti-CCP and rheumatoid factor, could anti-MCV be the next biomarker in the rheumatoid arthritis classification criteria?. Clinical Chemistry and Laboratory Medicine (CCLM). 57(11). 1668–1679. 27 indexed citations
7.
Wu, Huaxiang, et al.. (2019). Vasoactive intestinal peptide‐induced tolerogenic dendritic cells attenuated arthritis in experimental collagen‐induced arthritic mice. International Journal of Rheumatic Diseases. 22(7). 1255–1262. 10 indexed citations
11.
Li, Wenwen, Yong Liu, Xiaoyong Lu, et al.. (2015). A cross-sectional study of breath acetone based on diabetic metabolic disorders. Journal of Breath Research. 9(1). 16005–16005. 39 indexed citations
12.
Lu, Xiaoyong, et al.. (2014). Eosinophilic granulomatosis with polyangiitis complicated by cholecystitis: a case report and review of the literature. Clinical Rheumatology. 35(1). 259–263. 1 indexed citations
13.
Nie, Yuanyang, Xiaohui Luo, Jiuqiang Guan, et al.. (2014). Proteomic analysis of yak Longissimus dorsi muscle by two-dimensional electrophoresis. Meat Science. 101. 160–161. 3 indexed citations
14.
Cheng, Gang, et al.. (2007). Relationship between endothelial dysfunction, oxidant stress and aspirin resistance in patients with stable coronary heart disease. Journal of Clinical Pharmacy and Therapeutics. 32(3). 287–292. 11 indexed citations
15.
Yang, Xuyan, Jin Lin, Xiaoyong Lu, & Xiaoying Zhao. (2007). Expression of S100B protein levels in serum and cerebrospinal fluid with different forms of neuropsychiatric systemic lupus erythematosus. Clinical Rheumatology. 27(3). 353–357. 32 indexed citations
16.
Zhai, Guangju, Ariel Aviv, David J. Hunter, et al.. (2006). Reduction of leucocyte telomere length in radiographic hand osteoarthritis: a population-based study. Annals of the Rheumatic Diseases. 65(11). 1444–1448. 60 indexed citations
17.
Yang, Xuyan, et al.. (2005). [Clinical significance of CD4+CD25+ T cells in peripheral blood of patients in systemic lupus erythematosus].. PubMed. 44(8). 570–2. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026